Jeff Dueker
Saint Louis University
25 Papers
Jeff Dueker is an academic researcher from Saint Louis University. The author has contributed to research in topics: Medicine & Internal medicine. The author has an hindex of 1, co-authored 1 publications.
Chat about Author
Papers
Prospective evaluation of COVID-19 vaccine responses across a broad spectrum of immunocompromising conditions: the COVICS study.
Ghady Haidar,Mounzer E. Agha,Andrew Bilderback,Amy Lukanski,Kelsey Linstrum,R. Troyan,Scott D. Rothenberger,Deborah McMahon,Melissa D Crandall,M. Sobolewksi,P. Nathan Enick,Jana L. Jacobs,Kevin Collins,Cynthia Klamar-Blain,Bernard J.C. Macatangay,Urvi M. Parikh,Amy Heaps,Lindsay Coughenour,Marc Schwartz,Jeff Dueker,Fernanda P. Silveira,Mary E. Keebler,Abhinav Humar,James D. Luketich,Matthew R. Morrell,Joseph M. Pilewski,John F. McDyer,Bhanu P. Pappu,Robert L. Ferris,Stanley M. Marks,J.R. Mahon,Katie Mulvey,Sundaram Hariharan,Glenn Updike,Lorraine Brock,R.E. Edwards,Richard H. Beigi,P. L. Kip,Alan Wells,Tami Minnier,Derek C. Angus,John W. Mellors +41 more
TL;DR: Antibody responses to COVID-19 vaccines were lowest among SOT and anti-CD20 monoclonal recipients, and recipients of vaccines other than mRNA-1273, and among those with intermediate antibody levels, pseudovirus neutralization titers were lower in immunocompromised patients than HCW.
51
Prospective Evaluation of Coronavirus Disease 2019 (COVID-19) Vaccine Responses Across a Broad Spectrum of Immunocompromising Conditions: the COVID-19 Vaccination in the Immunocompromised Study (COVICS)
Ghady Haidar,Mounzer E. Agha,Andrew Bilderback,Amy Lukanski,Kelsey Linstrum,R. Troyan,Scott D. Rothenberger,Deborah McMahon,Melissa D Crandall,M. Sobolewksi,P. Nathan Enick,Jana L. Jacobs,Kevin Collins,Cynthia Klamar-Blain,Bernard J.C. Macatangay,Urvi M. Parikh,Amy Heaps,Lindsay Coughenour,Marc B Schwartz,Jeff Dueker,Fernanda P. Silveira,Mary E. Keebler,Abhinav Humar,James D. Luketich,Matthew R. Morrell,Joseph M. Pilewski,John F. McDyer,Bhanu P. Pappu,Robert L. Ferris,Stanley M. Marks,J.R. Mahon,Katie Mulvey,Sundaram Hariharan,Glenn Updike,Lorraine Brock,R.E. Edwards,Richard H. Beigi,P. L. Kip,Alan Wells,Tami Minnier,Derek C. Angus,John W. Mellors +41 more
TL;DR: Antibody responses to COVID-19 vaccines were lowest among SOT and anti-CD20 monoclonal recipients, and recipients of vaccines other than mRNA-1273, and among those with intermediate antibody levels, pseudovirus neutralization titers were lower in immunocompromised patients than HCWs.
Comparative Safety of Biologic Agents in Patients with Inflammatory Bowel Disease with Active or Recent Malignancy: A Multi-Center Cohort Study.
Ariela K. Holmer,Jiyu Luo,Kirk Russ,Sarah Park,Jeong Yun Yang,Furkan U. Ertem,Jeff Dueker,Vu T. Nguyen,Simon Hong,C. Zenger,Jordan E. Axelrad,Anthony M. Sofia,Jessica Petrov,Badr Al-Bawardy,David I. Fudman,Ernesto M. Llano,Joseph Dailey,Sushrut Jangi,Nidah S. Khakoo,Oriana M. Damas,E. Leon Barnes,Frank I. Scott,Ryan C. Ungaro,Siddharth Singh +23 more
TL;DR: In this paper , the authors compared the safety of tumor necrosis factor (TNF)-α antagonists vs non-TNF biologics in patients with inflammatory bowel disease (IBD) and active or recent cancer.
13
Granuloma Presence at Initial Surgery Predicts Need for Repeat Surgery Independent of Rutgeerts Score in Crohn's Disease.
Furkan U. Ertem,Claudia Ramos Rivers,A. T. Watson,Gong Tang,Marc Schwartz,Elyse Johnston,Arthur Barrie,Janet Harrison,Jeff Dueker,Doug Hartman,David G. Binion +10 more
TL;DR: In this paper , the authors evaluated the presence of epithelioid granuloma at first surgery and Rutgeerts score as a combined risk assessment for Crohn's disease surgical recurrence.
4